Abstract
Advances in genetic epidemiology have increased understanding of common, polygenic preventable diseases such as type 2 diabetes. As genetic risk testing based on this knowledge moves into clinical practice, we propose that genetic counselors will need to expand their roles and adapt traditional counseling techniques for this new patient set. In this paper, we present a genetic counseling intervention developed for a clinical trial [Genetic Counseling/Lifestyle Change for Diabetes Prevention, ClinicalTrials.gov identifier: NCT01034319] designed to motivate behavioral changes for diabetes prevention. Seventy-two phenotypically high-risk participants received counseling that included their diabetes genetic risk score, general education about diabetes risk factors, and encouragement to participate in a diabetes prevention program. Using two validated genetic counseling scales, participants reported favorable perceived control and satisfaction with the counseling session. Our intervention represents one model for applying traditional genetic counseling principles to risk testing for polygenetic, preventable diseases, such as type 2 diabetes.
Similar content being viewed by others
References
Austin, J. (2010). Reconceptualizing risk in genetic counseling: Implications for clinical practice. The Journal of Genetic Counseling, 19(3), 228–234.
Baty, B., Venne, V., McDonald, J., Croyle, R., Halls, C., Nash, J., et al. (1997). BRCA1 testing: Genetic counseling protocol development and counseling issues. The Journal of Genetic Counseling, 6(2), 223–244.
Bennett, P., Wilkinson, C., Turner, J., Brain, K., Edwards, R. T., Griffith, G., et al. (2008). Psychological factors associated with emotional responses to receiving genetic risk information. Journal of Genetic Counseling, 17, 234–241.
Centers for Disease Control and Prevention. (2011). National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta Georgia: U.S. Department of Health and Human services, Centers for Disease Control and Prevention.
Crandall, J. P., Knowler, W. C., Kahn, S. E., Marrero, D., Florez, J. C., Bray, G. A., et al. (2008). The prevention of type 2 diabetes. Nature Clinical Practice: Endocrine & Metabolism, 4(7), 382–393.
de Miguel-Yanes, J. M., Shrader, P., Pencina, M. J., Fox, C. S., Manning, A. K., Grant, R. W., et al. (2011). Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care, 34(1), 121–125.
DeMarco, T. A., Peshkin, B. N., Mars, B. D., & Tercyak, K. P. (2004). Patient satisfaction with cancer genetic counseling: a psychometric analysis of the genetic counseling satisfaction scale. Journal of Genetic Counseling, 13(4), 293–304.
Drake, E., Engler-Todd, L., O’Connor, A., Surh, L., & Hunter, A. (1999). Development and evaluation of a decision aid about prenatal testing for women of advanced maternal age. The Journal of Genetic Counseling, 8(4), 217–233.
Ford, E., Li, C., & Sattar, N. (2008). Metabolic syndrome and incident diabetes. Diabetes Care, 31(9), 1898–1904.
Foster, M. W., Mulvihill, J. J., & Sharp, R. R. (2008). Evaluating the utility of personal genomic information. Genetics in Medicine, 11(8), 570–574.
Gamm, J. L., Nussbaum, R. L., & Biesecker, B. B. (2004). Genetics and alcoholism among at-risk relatives I: Perceptions of cause, risk, and control. American Journal of Medical Genetics Part A, 128, 133–150.
Grant, R. W., Hivert, M., Pandiscio, J. C., Florez, J. C., Nathan, D. M., & Meigs, J. B. (2009). The clinical application of genetic testing in type 2 diabetes: A patient and physician survey. Diabetologia, 52(11), 2299–2305.
Hallowell, N., Statham, H., Murton, F., Green, J., & Richards, M. (1997). “Talking about chance”: The presentation of risk information during genetic counseling for breast and ovarian cancer. The Journal of Genetic Counseling, 6(3), 269–286.
Hettema, J., Steele, J., & Miller, M. R. (2005). Motivational interveiwing. Annual Review of Clinical Psychology, 1, 91–111.
Hivert, M. F., Grant, R. W., Shrader, P., & Meigs, J. B. (2009). Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records. BioMed Central Health Services Research, 9, 170.
Hivert, M. F., Jablonski, K. A., Perreault, L., Saxena, R., McAteer, J. B., Franks, P. W., et al. (2011). An updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the Diabetes Prevention Program. Diabetes, 60(4), 1340–1348.
Kaprio, J., Tuomilehto, J., Koskenvuo, M., Romanov, K., Reunanen, A., Eriksson, J., et al. (1992). Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia, 35(11), 1060–1067.
Kasparian, N. A., Wakefield, C. E., & Meiser, B. (2007). Assessment of psychosocial outcomes in genetic counseling research: An overview of available measurement scales. Journal of Genetic Counseling, 16, 693–712.
Markowitz, S. M., Park, E. R., Delahanty, L. M., O’Brien, K. E., & Grant, R. W. (2011). Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes. Diabetes Care, 34(3), 568–573.
Marteau, T. M., & Lerman, C. (2001). Genetic risk and behavioral change. British Medical Journal, 322, 1056–1059.
Marteau, T. M., French, D. P., Griffin, S. J., Prevost, A. T., Sutton, S., Watkinson, C., et al. (2010). Effects of communicating DNA-based disease risk estimates on risk-reducing behaviors (review). Cochrane Database of Systemic Reviews, 10, 1–77.
Meigs, J. B., Shrader, P., Sullivan, L. M., McAteer, J. B., Fox, C. S., Dupuis, J., et al. (2008). Genotype score in addition to common risk factors for prediction of type 2 diabetes. New England Journal of Medicine, 359(21), 2208–2219.
National Society of Genetic Counselors (2005). Definition/FAQ’s. Retrieved 5/27/2011, from http://www.nsgc.org/About/FAQsDefinitions/tabid/97/Default.aspx
O’Daniel, J. M. (2010). The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors. Journal of Genetic Counseling, 19(4), 315–327.
O’Daniel, J. M., Haga, S. B., & Willard, H. F. (2010). Considerations for the impact of personal genome information: A study of genomic profiling among genetics and genomics professionals. Journal of Genetic Counseling, 19(4), 387–401.
Resnik, D. B. (2003). Genetic testing and primary care: a new ethic for a new setting. New Genetics and Society, 22(3), 245–256.
Sanderson, S. C., Humphries, S. E., Hubbart, C., Hughes, E., Jarvis, M. J., & Wardle, J. (2008a). Psychological and behavioural impact of genetic testing smokers for lung cancer risk: A phase II exploratory trial. Journal of Health Psychology, 13(4), 481–494.
Sanderson, S. C., Wardle, J., & Humphries, S. E. (2008b). Public health genomics and genetic test evaluation: The challenge of conducting behavioral research on the utility of lifestyle-genetic tests. Journal of Nutrigenetics and Nutrigenomics, 1, 223–231.
Scheuner, M. T., Sieverding, P., & Shekell, P. G. (2008). Delivery of genomic medicine for common chronic adult diseases. A systemic review. Journal of the American Medical Association, 299(11), 1320–1334.
Sivell, S., Elwyn, G., Gaff, C. L., Clarke, A. J., Iredale, R., Shaw, C., et al. (2008). How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: Systemic review. The Journal of Genetic Counseling, 17(1), 30–63.
Smets, E. M., Pieterse, A. H., Aalfs, C. M., Ausems, M. G., & van Dulmen, A. M. (2006). The Perceived Personal Control (PPC) Questionnaire as an outcome of genetic counseling: Reliability and validity of the instrument. American Journal of Medical Genetics Part A, 140, 843–850.
Weil, J. (2000). Psychosocial genetic counseling. New York, NY: Oxford University Press, Inc.
Weil, J. (2003). Psychosocial genetic counseling in the post-nondirective era: A point of view. Journal of Genetic Counseling, 12(3), 199–211.
Weil, J., Ormond, K., Peters, J., Peters, K., Biesecker, B. B., & LeRoy, B. (2006). The relationship of nondirectiveness to genetic counseling: Report of a workshop at the 2003 NSGC Annual Education Conference. Journal of Genetic Counseling, 15(2), 85–93.
Acknowledgements
This work was funded by the National Institutes of Health (NIDDK R21 DK84527). Dr. Meigs is supported by NIDDK K24 DK080140.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Waxler, J.L., O’Brien, K.E., Delahanty, L.M. et al. Genetic Counseling as a Tool for Type 2 Diabetes Prevention: A Genetic Counseling Framework for Common Polygenetic Disorders. J Genet Counsel 21, 684–691 (2012). https://doi.org/10.1007/s10897-012-9486-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-012-9486-x